NDC 61314-476 – Hyrimoz
Adalimumab 20 mg/.2mL · Injection, Solution · Subcutaneous
Product NDC61314-476
Product details
- Brand name
- Hyrimoz
- Generic name
- Adalimumab-adaz
- Labeler
- Sandoz Inc
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761071
- Marketed since
- July 1, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Tumor Necrosis Factor Blocker
Active ingredients
- Adalimumab 20 mg/.2mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 61314-476-64 | 2 SYRINGE, GLASS in 1 CARTON (61314-476-64) / .2 mL in 1 SYRINGE, GLASS | Jul 1, 2023 |
Other Hyrimoz products
- 83457-100 Adalimumab 40 mg/.4mL · Injection, Solution · Cordavis Limited
- 83457-101 Adalimumab 40 mg/.4mL · Injection, Solution · Cordavis Limited
- 83457-102 Adalimumab 40 mg/.8mL · Injection, Solution · Cordavis Limited
- 83457-103 Adalimumab 40 mg/.8mL · Injection, Solution · Cordavis Limited
- 83457-107 Adalimumab 80 mg/.8mL · Injection, Solution · Cordavis Limited
- 83457-108 Adalimumab 20 mg/.2mL · Injection, Solution · Cordavis Limited
- 83457-113 Adalimumab 80 mg/.8mL · Injection, Solution · Cordavis Limited
- 61314-454 Adalimumab 80 mg/.8mL · Injection, Solution · Sandoz Inc
- 61314-473 Adalimumab 40 mg/.4mL · Injection, Solution · Sandoz Inc
- 61314-509 Adalimumab 10 mg/.1mL · Injection, Solution · Sandoz Inc
- 83457-112 · Kit · Cordavis Limited
- 61314-517 · Kit · Sandoz Inc